We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+9.9%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$30.8B
AUM Growth
+$2.83B
(+10%)
Cap. Flow
+$314M
Cap. Flow
% of AUM
1.02%
Top 10 Holdings %
Top 10 Hldgs %
29.43%
Holding
995
New
101
Increased
392
Reduced
278
Closed
51
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$434M |
| 2 |
Estee Lauder
EL
|
+$90.8M |
| 3 |
Visa
V
|
+$90M |
| 4 |
Amphenol
APH
|
+$67.6M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$57.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$409M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$322M |
| 3 |
Apple
AAPL
|
+$115M |
| 4 |
TotalEnergies
TTE
|
+$31.5M |
| 5 |
Deckers Outdoor
DECK
|
+$27.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 15.56% |
| 3 | Financials | 11.89% |
| 4 | Industrials | 9.57% |
| 5 | Energy | 9.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWC
101
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $46M | 0.15% |
339,788
-112,504
| -25% | -$14M |
|
102
Freeport-McMoran
FCX
$91.3B
| $45.8M | 0.15% |
1,214,443
+79,243
| +7% | +$2.81M |
|
103
Pricesmart
PSMT
$5.76B
| $44.9M | 0.15% |
388,769
+19,290
| +5% | +$2.17M |
|
104
Philip Morris
PM
$298B
| $44.6M | 0.14% |
512,196
+7,296
| +1% | +$637K |
|
105
HEICO Corp
HEI
$47.6B
| $43.9M | 0.14% |
1,849,822
+56,289
| +3% | +$1.27M |
|
|
ESV
106
DELISTED
Ensco Rowan plc
ESV
| $43.6M | 0.14% |
190,501
+183,078
| +2,466% | +$42.3M |
|
107
Canadian Pacific Kansas City
CP
$82B
| $41.3M | 0.13% |
1,365,960
-224,460
| -14% | -$6.47M |
|
|
CYN
108
DELISTED
CITY NATIONAL CORPORATION
CYN
| $41.2M | 0.13% |
520,599
+118,104
| +29% | +$8.71M |
|
109
Crown Castle
CCI
$32.6B
| $41.1M | 0.13% |
559,907
+5,608
| +1% | +$415K |
|
110
General Motors
GM
$73B
| $41M | 0.13% |
1,004,319
+16,108
| +2% | +$609K |
|
111
IDEX
IEX
$16.4B
| $40.8M | 0.13% |
552,520
+1,990
| +0.4% | +$138K |
|
112
Microchip Technology
MCHP
$44.2B
| $40.6M | 0.13% |
1,813,034
+103,188
| +6% | +$2.16M |
|
113
Northern Trust
NTRS
$21.9B
| $39.7M | 0.13% |
640,866
+49,664
| +8% | +$2.85M |
|
|
HOLX
114
DELISTED
Hologic
HOLX
| $39.7M | 0.13% |
1,774,484
+401,907
| +29% | +$8.86M |
|
|
ROC
115
DELISTED
ROCKWOOD HLDGS INC
ROC
| $39M | 0.13% |
542,354
+94,351
| +21% | +$6.42M |
|
116
AbbVie
ABBV
$454B
| $38.2M | 0.12% |
723,866
-12,879
| -2% | -$633K |
|
117
Automatic Data Processing
ADP
$97.1B
| $37.8M | 0.12% |
532,242
-3,986
| -0.7% | -$268K |
|
|
AAN.A
118
DELISTED
The Aaron's Company Inc Class A
AAN.A
| $37.6M | 0.12% |
1,280,118
+5,839
| +0.5% | +$172K |
|
119
Arch Capital
ACGL
$35B
| $37.2M | 0.12% |
1,868,595
-27,765
| -1% | -$533K |
|
|
ECHO
120
EchoStar
ECHO
$26.5B
| $37.1M | 0.12% |
921,166
+55,132
| +6% | +$2.15M |
|
|
CEB
121
DELISTED
CEB Inc.
CEB
| $36.9M | 0.12% |
476,058
+16,707
| +4% | +$1.23M |
|
122
Henry Schein
HSIC
$9.63B
| $36.7M | 0.12% |
818,537
-11,210
| -1% | -$490K |
|
123
Chevron
CVX
$387B
| $36.3M | 0.12% |
290,290
-1,303
| -0.4% | -$157K |
|
|
GES
124
DELISTED
Guess Inc
GES
| $36M | 0.12% |
1,159,720
+82,281
| +8% | +$2.61M |
|
125
Coca-Cola
KO
$349B
| $35.9M | 0.12% |
870,087
-129
| -0% | -$5.09K |
|
Similar funds
QCM
Brown Advisory's Q4 2013 Portfolio in Review
As of Q4 2013, Brown Advisory held 995 positions worth $30.8B, up 10% from $28B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Brown Advisory's Q4 2013 filing shows 101 new, 392 increased, 278 reduced and 51 closed positions. Its largest new stake was Plains GP Holdings: 157,910 shares worth $11.3M. The largest sale was Idexx Laboratories, an estimated $409M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q4 2013 buy was Plains GP Holdings: 157,910 shares worth $11.3M.
- Brown Advisory added most to Gilead Sciences in Q4 2013, an estimated $434M increase.
- Brown Advisory's biggest Q4 2013 reduction was Idexx Laboratories, cutting an estimated $409M.
- Brown Advisory fully exited Ariad Pharmaceuticals Inc in Q4 2013, selling an estimated $19.5M.
- Brown Advisory's ten largest holdings make up 29% of its $30.8B portfolio in Q4 2013.
- Brown Advisory opened 101 new positions and closed 51 in Q4 2013.
- Brown Advisory's portfolio value rose 10% quarter-over-quarter to $30.8B.
Based on Brown Advisory's 13F filing for Q4 2013, filed 11 Feb 2014.